NanoLAS

NanoLAS aggregates and curates nanobody sequence and annotation data from multiple sources to provide a centralized database supporting research on camelid-derived single heavy chain variable region antibodies (nanobodies) and their therapeutic applications.

Key Features:

• Comprehensive Data Integration: Integrates and consolidates nanobody sequences and annotations from multiple external sources into a single curated database.
• Camelid-derived Nanobody Annotation: Retains taxonomic and structural metadata for camelid-origin nanobodies, including single heavy chain variable region information.
• Biophysical Metadata: Records properties such as the reduced molecular weight of nanobodies relative to conventional antibodies.
• Latest Data Inclusion: Incorporates the most recent nanobody entries and updates from integrated sources.

Scientific Applications:

• Therapeutic development: Supports identification, selection, and comparison of nanobodies for disease treatment and other biomedical applications.
• Sequence-based research: Enables retrieval of curated sequence and annotation data for structural, functional, and comparative studies of nanobodies.

Methodology:

Integration and consolidation of existing nanobody data from multiple sources into a single curated database.